SILENCE THERAPEUTICS PLC
Institutional coverage
54 13F filers hold $SLN.
13F holders
54
Insider buys · 90d
0
Congress · 90d
0
Smart Money · top-200 alpha cohort
2 holders · Q1 2026Fewer than 3 top-performer holders hold this ticker — not enough signal for a Smart-Money commentary this week. The institutional holders table below shows the full picture.
Smart Money shows holdings from our Top-Performer cohort — the 200 highest-alpha manager_13f funds in our universe. Position weight (current quarter) and QoQ delta versus prior quarter. α is the manager's annual alpha vs benchmark.
Institutional holders
Top 10 of 54 · Source: 13F-HR01
Vida Ventures Advisors, LLC
0.46% of portfolio
6,067,120 sh
02
GSG Advisors LLC
0.43% of portfolio
2,911,438 sh
03
Silver Lake Group, L.L.C.
0.76% of portfolio
2,164,777 sh
04
Wallace Capital Management Inc.
0.42% of portfolio
2,146,731 sh
05
Evergreen Capital Management LLC
—
1,074,191 sh
06
Scopia Capital Management LP
1.24% of portfolio
1,020,489 sh
07
Garde Capital, Inc.
0.35% of portfolio
952,400 sh
08
Liberty Wealth Management LLC
0.14% of portfolio
865,784 sh
09
Martin Investment Management, LLC
0.64% of portfolio
630,161 sh
10
5AM Venture Management, LLC
0.91% of portfolio
476,200 sh
Insider activity · last 90 days
No insider activity
No Form 4 filings on record for $SLN in the recent window.
Congress trades · last 90 days
No Congress trades
No STOCK Act filings reference $SLN in the recent window.
Source data: SEC EDGAR · 13F-HR · Form 4 · U.S. House Clerk PTR (disclosures-clerk.house.gov) · Senate eFD (senate.gov) · Last refreshed 13:08 UTC.